Abstract
Although nearly two-third of bankruptcy in the United States is medical in origin, a common assumption is that individuals facing a potentially lethal disease opt for cure at any cost. This assumption has never been tested, and knowledge of how the American population values a trade-off between cure and bankruptcy is unknown.
Keywords
discrete choice analysishealth care costsmedical bankruptcy;
Reference
M.G Shrime, M.C. Weinstein, James K. Hammitt, Jessica Cohen, and Joshua Salomon, “Trading Bankruptcy for Health: A Discrete-Choice Experiment”, Value in Health, vol. 21, n. 1, January 2018, pp. 95–104.
See also
Published in
Value in Health, vol. 21, n. 1, January 2018, pp. 95–104